Technical Description
The present disclosure relates to a graphene-based composite i.e., Zn-SnO2/NG hybrid composite modified GC that exhibits good electrochemical redox behavior and helps in sensing dopamine, cholesterol, and glucose on a single platform.
Problems Addressed
- Limitations of Existing Methods
- Multi-Platform Sensing
- Error Prone & Lacks Reproducibility
- No Real-time Monitoring
- Slow Kinetics
Tech Features
- Affordable
- Single-Platform Sensing
- Less Prone to Error
- Reproducibility
- Real-time Monitoring
- Excellent Electrochemical Performance
Target Audience
- Medical & Healthcare Sector
- Medical Device Manufacturing Sector
- Environmental Monitoring Sector
- Research and Development
Tech ID: P24-1623 TRL 3 Patent Status: Granted Available For Exclusive and Non-exclusive License
